EU Drug Regulator Said To Have Called DCGI Over Ranbaxy Concerns
This article was originally published in PharmAsia News
Executive Summary
The European Union's drug regulator reportedly has contacted his India counterpart directly to discuss Ranbaxy Laboratories and its problem-plagued production facilities.